0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538
Global CAR TCell Therapy for Multiple Myeloma Market Size Status and Forecast 20192025
Published Date: March 2019
|
Report Code: QYRE-Othe-164
Home | Category |Health |Health Conditions |Cancer
Global CAR TCell Therapy for Multiple Myeloma Market Size Status and Forecast 20192025

Global CAR TCell Therapy for Multiple Myeloma Market Size Status and Forecast 20192025

Code: QYRE-Othe-164
Report
March 2019
95 Pages
QYResearch
Region: Europe, North America, Asia Pacific,
Description
Table of Content
Tables & Figures

"CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it is yet to receive an approval of the first CAR T-cell therapy for multiple myeloma. 
The increasing number of collaborations or licensing agreements between companies and research institute, will induce the involvement of more investors in this area. Car T-cell therapy for multiple myeloma has identified that most of the pipeline molecules in multiple myeloma are currently in the pre-clinical development stage. KMA.CAR-T the drug is under development by the company HaemaLogiX. This monotherapy drug is currently in the pre-clinical stage and the company has already signed an agreement with Westmead Institute for Medical Research.
In 2018, the global CAR T-Cell Therapy for Multiple Myeloma market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global CAR T-Cell Therapy for Multiple Myeloma status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CAR T-Cell Therapy for Multiple Myeloma development in United States, Europe and China.

The key players covered in this study
Juno Therapeutics
Kite Pharma
Novartis
Collectis
...

Market segment by Type, the product can be split into
Monotherapy
Combination Therapy

Market segment by Application, split into
Multiple Myeloma
Refractory or Relapsed Multiple Myeloma

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global CAR T-Cell Therapy for Multiple Myeloma status, future forecast, growth opportunity, key market and key players.
To present the CAR T-Cell Therapy for Multiple Myeloma development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of CAR T-Cell Therapy for Multiple Myeloma are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
"

"Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Size Growth Rate by Type (2014-2025)
1.4.2 Monotherapy
1.4.3 Combination Therapy
1.5 Market by Application
1.5.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2014-2025)
1.5.2 Multiple Myeloma
1.5.3 Refractory or Relapsed Multiple Myeloma
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 CAR T-Cell Therapy for Multiple Myeloma Market Size
2.2 CAR T-Cell Therapy for Multiple Myeloma Growth Trends by Regions
2.2.1 CAR T-Cell Therapy for Multiple Myeloma Market Size by Regions (2014-2025)
2.2.2 CAR T-Cell Therapy for Multiple Myeloma Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 CAR T-Cell Therapy for Multiple Myeloma Market Size by Manufacturers
3.1.1 Global CAR T-Cell Therapy for Multiple Myeloma Revenue by Manufacturers (2014-2019)
3.1.2 Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global CAR T-Cell Therapy for Multiple Myeloma Market Concentration Ratio (CR5 and HHI)
3.2 CAR T-Cell Therapy for Multiple Myeloma Key Players Head office and Area Served
3.3 Key Players CAR T-Cell Therapy for Multiple Myeloma Product/Solution/Service
3.4 Date of Enter into CAR T-Cell Therapy for Multiple Myeloma Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2014-2019)
4.2 Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2014-2019)

5 United States
5.1 United States CAR T-Cell Therapy for Multiple Myeloma Market Size (2014-2019)
5.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in United States
5.3 United States CAR T-Cell Therapy for Multiple Myeloma Market Size by Type
5.4 United States CAR T-Cell Therapy for Multiple Myeloma Market Size by Application

6 Europe
6.1 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size (2014-2019)
6.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in Europe
6.3 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Type
6.4 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Application

7 China
7.1 China CAR T-Cell Therapy for Multiple Myeloma Market Size (2014-2019)
7.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in China
7.3 China CAR T-Cell Therapy for Multiple Myeloma Market Size by Type
7.4 China CAR T-Cell Therapy for Multiple Myeloma Market Size by Application

8 Japan
8.1 Japan CAR T-Cell Therapy for Multiple Myeloma Market Size (2014-2019)
8.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in Japan
8.3 Japan CAR T-Cell Therapy for Multiple Myeloma Market Size by Type
8.4 Japan CAR T-Cell Therapy for Multiple Myeloma Market Size by Application

9 Southeast Asia
9.1 Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size (2014-2019)
9.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in Southeast Asia
9.3 Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size by Type
9.4 Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size by Application

10 India
10.1 India CAR T-Cell Therapy for Multiple Myeloma Market Size (2014-2019)
10.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in India
10.3 India CAR T-Cell Therapy for Multiple Myeloma Market Size by Type
10.4 India CAR T-Cell Therapy for Multiple Myeloma Market Size by Application

11 Central & South America
11.1 Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size (2014-2019)
11.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in Central & South America
11.3 Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size by Type
11.4 Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size by Application

12 International Players Profiles
12.1 Juno Therapeutics
12.1.1 Juno Therapeutics Company Details
12.1.2 Company Description and Business Overview
12.1.3 CAR T-Cell Therapy for Multiple Myeloma Introduction
12.1.4 Juno Therapeutics Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)
12.1.5 Juno Therapeutics Recent Development
12.2 Kite Pharma
12.2.1 Kite Pharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 CAR T-Cell Therapy for Multiple Myeloma Introduction
12.2.4 Kite Pharma Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)
12.2.5 Kite Pharma Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 CAR T-Cell Therapy for Multiple Myeloma Introduction
12.3.4 Novartis Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Collectis
12.4.1 Collectis Company Details
12.4.2 Company Description and Business Overview
12.4.3 CAR T-Cell Therapy for Multiple Myeloma Introduction
12.4.4 Collectis Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)
12.4.5 Collectis Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
"

"List of Tables and Figures

Table CAR T-Cell Therapy for Multiple Myeloma Key Market Segments
Table Key Players CAR T-Cell Therapy for Multiple Myeloma Covered
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size Market Share by Type 2014-2025
Figure Monotherapy Figures
Table Key Players of Monotherapy
Figure Combination Therapy Figures
Table Key Players of Combination Therapy
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size Growth by Application 2014-2025 (Million US$)
Figure Multiple Myeloma Case Studies
Figure Refractory or Relapsed Multiple Myeloma Case Studies
Figure CAR T-Cell Therapy for Multiple Myeloma Report Years Considered
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size 2014-2025 (Million US$)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size and Growth Rate 2014-2025 (Million US$)
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Regions 2014-2025 (Million US$)
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Regions 2014-2019 (Million US$)
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Regions 2014-2019
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Regions 2014-2019
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Regions 2019
Table Market Top Trends
Table Global CAR T-Cell Therapy for Multiple Myeloma Revenue by Manufacturers (2014-2019) (Million US$)
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Manufacturers (2014-2019)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Manufacturers in 2018
Table Global CAR T-Cell Therapy for Multiple Myeloma Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players CAR T-Cell Therapy for Multiple Myeloma Product/Solution/Service
Table Date of Enter into CAR T-Cell Therapy for Multiple Myeloma Market
Table Mergers & Acquisitions, Expansion Plans
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2014-2019) (Million US$)
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Type (2014-2019)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size Market Share by Type (2014-2019)
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2014-2019) (Million US$)
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Application (2014-2019)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size Market Share by Application (2014-2019)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Application in 2018
Figure United States CAR T-Cell Therapy for Multiple Myeloma Market Size 2014-2019 (Million US$)
Table United States Key Players CAR T-Cell Therapy for Multiple Myeloma Revenue (2018-2019) (Million US$)
Table United States Key Players CAR T-Cell Therapy for Multiple Myeloma Market Share (2018-2019)
Table United States CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2014-2019) (Million US$)
Table United States CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2014-2019)
Table United States CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2014-2019) (Million US$)
Table United States CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2014-2019)
Figure Europe CAR T-Cell Therapy for Multiple Myeloma Market Size 2014-2019 (Million US$)
Table Europe Key Players CAR T-Cell Therapy for Multiple Myeloma Revenue (2018-2019) (Million US$)
Table Europe Key Players CAR T-Cell Therapy for Multiple Myeloma Market Share (2018-2019)
Table Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2014-2019) (Million US$)
Table Europe CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2014-2019)
Table Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2014-2019) (Million US$)
Table Europe CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2014-2019)
Figure China CAR T-Cell Therapy for Multiple Myeloma Market Size 2014-2019 (Million US$)
Table China Key Players CAR T-Cell Therapy for Multiple Myeloma Revenue (2018-2019) (Million US$)
Table China Key Players CAR T-Cell Therapy for Multiple Myeloma Market Share (2018-2019)
Table China CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2014-20189) (Million US$)
Table China CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2014-2019)
Table China CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2014-2019) (Million US$)
Table China CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2014-2019)
Figure Japan CAR T-Cell Therapy for Multiple Myeloma Market Size 2014-2019 (Million US$)
Table Japan Key Players CAR T-Cell Therapy for Multiple Myeloma Revenue (2018-2019) (Million US$)
Table Japan Key Players CAR T-Cell Therapy for Multiple Myeloma Market Share (2018-2019)
Table Japan CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2014-2019) (Million US$)
Table Japan CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2014-2019)
Table Japan CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2014-2019) (Million US$)
Table Japan CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2014-2019)
Figure Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players CAR T-Cell Therapy for Multiple Myeloma Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players CAR T-Cell Therapy for Multiple Myeloma Market Share (2018-2019)
Table Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2014-2019)
Table Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2014-2019)
Figure India CAR T-Cell Therapy for Multiple Myeloma Market Size 2014-2019 (Million US$)
Table India Key Players CAR T-Cell Therapy for Multiple Myeloma Revenue (2018-2019) (Million US$)
Table India Key Players CAR T-Cell Therapy for Multiple Myeloma Market Share (2018-2019)
Table India CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2014-2019) (Million US$)
Table India CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2014-2019)
Table India CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2014-2019) (Million US$)
Table India CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2014-2019)
Figure Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size 2014-2019 (Million US$)
Table Central & South America Key Players CAR T-Cell Therapy for Multiple Myeloma Revenue (2018-2019) (Million US$)
Table Central & South America Key Players CAR T-Cell Therapy for Multiple Myeloma Market Share (2018-2019)
Table Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2014-2019) (Million US$)
Table Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2014-2019)
Table Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2014-2019) (Million US$)
Table Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2014-2019)
Table Juno Therapeutics Company Details
Table Juno Therapeutics Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019) (Million US$)
Figure Juno Therapeutics Revenue Growth Rate in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)
Table Juno Therapeutics Recent Development
Table Kite Pharma Company Details
Table Kite Pharma Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)(Million US$)
Figure Kite Pharma Revenue Growth Rate in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)
Table Kite Pharma Recent Development
Table Novartis Company Details
Table Novartis Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)
Table Novartis Recent Development
Table Collectis Company Details
Table Collectis Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)(Million US$)
Figure Collectis Revenue Growth Rate in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)
Table Collectis Recent Development
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Regions (Million US$) 2019-2025
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Regions (2019-2025)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Regions in 2025
Figure United States CAR T-Cell Therapy for Multiple Myeloma Market Size Forecast (2019-2025)(Million USD)
Figure Europe CAR T-Cell Therapy for Multiple Myeloma Market Size Forecast (2019-2025)(Million USD)
Figure China CAR T-Cell Therapy for Multiple Myeloma Market Size Forecast (2019-2025)(Million USD)
Figure Japan CAR T-Cell Therapy for Multiple Myeloma Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size Forecast (2019-2025)(Million USD)
Figure India CAR T-Cell Therapy for Multiple Myeloma Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size Forecast (2019-2025)(Million USD)
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Product (2019-2025) (Million US$)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Product (2019-2025)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Product in 2025
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2019-2025) (Million US$)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2019-2025)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
"

 

"CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it is yet to receive an approval of the first CAR T-cell therapy for multiple myeloma. 
The increasing number of collaborations or licensing agreements between companies and research institute, will induce the involvement of more investors in this area. Car T-cell therapy for multiple myeloma has identified that most of the pipeline molecules in multiple myeloma are currently in the pre-clinical development stage. KMA.CAR-T the drug is under development by the company HaemaLogiX. This monotherapy drug is currently in the pre-clinical stage and the company has already signed an agreement with Westmead Institute for Medical Research.
In 2018, the global CAR T-Cell Therapy for Multiple Myeloma market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global CAR T-Cell Therapy for Multiple Myeloma status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CAR T-Cell Therapy for Multiple Myeloma development in United States, Europe and China.

The key players covered in this study
Juno Therapeutics
Kite Pharma
Novartis
Collectis
...

Market segment by Type, the product can be split into
Monotherapy
Combination Therapy

Market segment by Application, split into
Multiple Myeloma
Refractory or Relapsed Multiple Myeloma

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global CAR T-Cell Therapy for Multiple Myeloma status, future forecast, growth opportunity, key market and key players.
To present the CAR T-Cell Therapy for Multiple Myeloma development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of CAR T-Cell Therapy for Multiple Myeloma are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
"

Read More

"Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Size Growth Rate by Type (2014-2025)
1.4.2 Monotherapy
1.4.3 Combination Therapy
1.5 Market by Application
1.5.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2014-2025)
1.5.2 Multiple Myeloma
1.5.3 Refractory or Relapsed Multiple Myeloma
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 CAR T-Cell Therapy for Multiple Myeloma Market Size
2.2 CAR T-Cell Therapy for Multiple Myeloma Growth Trends by Regions
2.2.1 CAR T-Cell Therapy for Multiple Myeloma Market Size by Regions (2014-2025)
2.2.2 CAR T-Cell Therapy for Multiple Myeloma Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 CAR T-Cell Therapy for Multiple Myeloma Market Size by Manufacturers
3.1.1 Global CAR T-Cell Therapy for Multiple Myeloma Revenue by Manufacturers (2014-2019)
3.1.2 Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global CAR T-Cell Therapy for Multiple Myeloma Market Concentration Ratio (CR5 and HHI)
3.2 CAR T-Cell Therapy for Multiple Myeloma Key Players Head office and Area Served
3.3 Key Players CAR T-Cell Therapy for Multiple Myeloma Product/Solution/Service
3.4 Date of Enter into CAR T-Cell Therapy for Multiple Myeloma Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2014-2019)
4.2 Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2014-2019)

5 United States
5.1 United States CAR T-Cell Therapy for Multiple Myeloma Market Size (2014-2019)
5.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in United States
5.3 United States CAR T-Cell Therapy for Multiple Myeloma Market Size by Type
5.4 United States CAR T-Cell Therapy for Multiple Myeloma Market Size by Application

6 Europe
6.1 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size (2014-2019)
6.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in Europe
6.3 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Type
6.4 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Application

7 China
7.1 China CAR T-Cell Therapy for Multiple Myeloma Market Size (2014-2019)
7.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in China
7.3 China CAR T-Cell Therapy for Multiple Myeloma Market Size by Type
7.4 China CAR T-Cell Therapy for Multiple Myeloma Market Size by Application

8 Japan
8.1 Japan CAR T-Cell Therapy for Multiple Myeloma Market Size (2014-2019)
8.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in Japan
8.3 Japan CAR T-Cell Therapy for Multiple Myeloma Market Size by Type
8.4 Japan CAR T-Cell Therapy for Multiple Myeloma Market Size by Application

9 Southeast Asia
9.1 Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size (2014-2019)
9.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in Southeast Asia
9.3 Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size by Type
9.4 Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size by Application

10 India
10.1 India CAR T-Cell Therapy for Multiple Myeloma Market Size (2014-2019)
10.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in India
10.3 India CAR T-Cell Therapy for Multiple Myeloma Market Size by Type
10.4 India CAR T-Cell Therapy for Multiple Myeloma Market Size by Application

11 Central & South America
11.1 Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size (2014-2019)
11.2 CAR T-Cell Therapy for Multiple Myeloma Key Players in Central & South America
11.3 Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size by Type
11.4 Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size by Application

12 International Players Profiles
12.1 Juno Therapeutics
12.1.1 Juno Therapeutics Company Details
12.1.2 Company Description and Business Overview
12.1.3 CAR T-Cell Therapy for Multiple Myeloma Introduction
12.1.4 Juno Therapeutics Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)
12.1.5 Juno Therapeutics Recent Development
12.2 Kite Pharma
12.2.1 Kite Pharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 CAR T-Cell Therapy for Multiple Myeloma Introduction
12.2.4 Kite Pharma Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)
12.2.5 Kite Pharma Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 CAR T-Cell Therapy for Multiple Myeloma Introduction
12.3.4 Novartis Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Collectis
12.4.1 Collectis Company Details
12.4.2 Company Description and Business Overview
12.4.3 CAR T-Cell Therapy for Multiple Myeloma Introduction
12.4.4 Collectis Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)
12.4.5 Collectis Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
"

Read More

"List of Tables and Figures

Table CAR T-Cell Therapy for Multiple Myeloma Key Market Segments
Table Key Players CAR T-Cell Therapy for Multiple Myeloma Covered
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size Market Share by Type 2014-2025
Figure Monotherapy Figures
Table Key Players of Monotherapy
Figure Combination Therapy Figures
Table Key Players of Combination Therapy
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size Growth by Application 2014-2025 (Million US$)
Figure Multiple Myeloma Case Studies
Figure Refractory or Relapsed Multiple Myeloma Case Studies
Figure CAR T-Cell Therapy for Multiple Myeloma Report Years Considered
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size 2014-2025 (Million US$)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size and Growth Rate 2014-2025 (Million US$)
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Regions 2014-2025 (Million US$)
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Regions 2014-2019 (Million US$)
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Regions 2014-2019
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Regions 2014-2019
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Regions 2019
Table Market Top Trends
Table Global CAR T-Cell Therapy for Multiple Myeloma Revenue by Manufacturers (2014-2019) (Million US$)
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Manufacturers (2014-2019)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Manufacturers in 2018
Table Global CAR T-Cell Therapy for Multiple Myeloma Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players CAR T-Cell Therapy for Multiple Myeloma Product/Solution/Service
Table Date of Enter into CAR T-Cell Therapy for Multiple Myeloma Market
Table Mergers & Acquisitions, Expansion Plans
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2014-2019) (Million US$)
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Type (2014-2019)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size Market Share by Type (2014-2019)
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2014-2019) (Million US$)
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Application (2014-2019)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size Market Share by Application (2014-2019)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Application in 2018
Figure United States CAR T-Cell Therapy for Multiple Myeloma Market Size 2014-2019 (Million US$)
Table United States Key Players CAR T-Cell Therapy for Multiple Myeloma Revenue (2018-2019) (Million US$)
Table United States Key Players CAR T-Cell Therapy for Multiple Myeloma Market Share (2018-2019)
Table United States CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2014-2019) (Million US$)
Table United States CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2014-2019)
Table United States CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2014-2019) (Million US$)
Table United States CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2014-2019)
Figure Europe CAR T-Cell Therapy for Multiple Myeloma Market Size 2014-2019 (Million US$)
Table Europe Key Players CAR T-Cell Therapy for Multiple Myeloma Revenue (2018-2019) (Million US$)
Table Europe Key Players CAR T-Cell Therapy for Multiple Myeloma Market Share (2018-2019)
Table Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2014-2019) (Million US$)
Table Europe CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2014-2019)
Table Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2014-2019) (Million US$)
Table Europe CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2014-2019)
Figure China CAR T-Cell Therapy for Multiple Myeloma Market Size 2014-2019 (Million US$)
Table China Key Players CAR T-Cell Therapy for Multiple Myeloma Revenue (2018-2019) (Million US$)
Table China Key Players CAR T-Cell Therapy for Multiple Myeloma Market Share (2018-2019)
Table China CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2014-20189) (Million US$)
Table China CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2014-2019)
Table China CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2014-2019) (Million US$)
Table China CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2014-2019)
Figure Japan CAR T-Cell Therapy for Multiple Myeloma Market Size 2014-2019 (Million US$)
Table Japan Key Players CAR T-Cell Therapy for Multiple Myeloma Revenue (2018-2019) (Million US$)
Table Japan Key Players CAR T-Cell Therapy for Multiple Myeloma Market Share (2018-2019)
Table Japan CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2014-2019) (Million US$)
Table Japan CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2014-2019)
Table Japan CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2014-2019) (Million US$)
Table Japan CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2014-2019)
Figure Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players CAR T-Cell Therapy for Multiple Myeloma Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players CAR T-Cell Therapy for Multiple Myeloma Market Share (2018-2019)
Table Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2014-2019)
Table Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2014-2019)
Figure India CAR T-Cell Therapy for Multiple Myeloma Market Size 2014-2019 (Million US$)
Table India Key Players CAR T-Cell Therapy for Multiple Myeloma Revenue (2018-2019) (Million US$)
Table India Key Players CAR T-Cell Therapy for Multiple Myeloma Market Share (2018-2019)
Table India CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2014-2019) (Million US$)
Table India CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2014-2019)
Table India CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2014-2019) (Million US$)
Table India CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2014-2019)
Figure Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size 2014-2019 (Million US$)
Table Central & South America Key Players CAR T-Cell Therapy for Multiple Myeloma Revenue (2018-2019) (Million US$)
Table Central & South America Key Players CAR T-Cell Therapy for Multiple Myeloma Market Share (2018-2019)
Table Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2014-2019) (Million US$)
Table Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2014-2019)
Table Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2014-2019) (Million US$)
Table Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2014-2019)
Table Juno Therapeutics Company Details
Table Juno Therapeutics Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019) (Million US$)
Figure Juno Therapeutics Revenue Growth Rate in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)
Table Juno Therapeutics Recent Development
Table Kite Pharma Company Details
Table Kite Pharma Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)(Million US$)
Figure Kite Pharma Revenue Growth Rate in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)
Table Kite Pharma Recent Development
Table Novartis Company Details
Table Novartis Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)
Table Novartis Recent Development
Table Collectis Company Details
Table Collectis Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)(Million US$)
Figure Collectis Revenue Growth Rate in CAR T-Cell Therapy for Multiple Myeloma Business (2014-2019)
Table Collectis Recent Development
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Regions (Million US$) 2019-2025
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Regions (2019-2025)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Regions in 2025
Figure United States CAR T-Cell Therapy for Multiple Myeloma Market Size Forecast (2019-2025)(Million USD)
Figure Europe CAR T-Cell Therapy for Multiple Myeloma Market Size Forecast (2019-2025)(Million USD)
Figure China CAR T-Cell Therapy for Multiple Myeloma Market Size Forecast (2019-2025)(Million USD)
Figure Japan CAR T-Cell Therapy for Multiple Myeloma Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size Forecast (2019-2025)(Million USD)
Figure India CAR T-Cell Therapy for Multiple Myeloma Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size Forecast (2019-2025)(Million USD)
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Product (2019-2025) (Million US$)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Product (2019-2025)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Product in 2025
Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2019-2025) (Million US$)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2019-2025)
Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
"

 

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Multi User

Electronic (PDF)
$5850
This license allows multiple user to access the PDF.

Enterprise License

Electronic (PDF)
$7800
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)

RELATED REPORTS

0 Items
X
No items in the cart.
$0.0